Britons want bowel cancer screening recommendation

December 5, 2012
Britons want bowel cancer screening recommendation

Britons want a recommendation from the NHS on whether to attend bowel cancer screening, along with all the information on benefits and risks, according to research published in the British Journal of Cancer today.

The study involved interviews with nearly 2,000 UK adults aged 50-80, asking if they would prefer a recommendation to be screened for from the or advised to make the decision themselves. They were also asked if they wanted to know about all the risks and benefits.

Eighty four per cent wanted an NHS recommendation to attend screening and more than three quarters of those asked wanted all the available information.

There was no difference in the for a recommendation between richer and poorer people or between older and younger. But men were more likely than women to want a recommendation.

By 2025, it is predicted that bowel screening will save over 2,000 lives from bowel cancer each year in the UK.  Like all , bowel is not perfect. People sometimes get a 'false positive' result. This means they are sent for follow-up tests (which can be worrying and they have risks of their own) but nothing is found. People also sometimes get false negatives, meaning a cancer could be missed.

New technologies are being developed and introduced into the bowel cancer screening programme in England. In 2010, Cancer Research UK helped to fund a trial into the use of the Flexi-scope.  This new one-off test for people in their mid-fifties can prevent bowel cancer from developing by finding and removing that could otherwise turn into cancers. The government has promised to fund a national programme of Flexi-scope screening due to start early next year.

Professor Jane Wardle, lead author and director of Cancer Research UK's Research Centre at UCL, said: "We have seen that most people who wanted a screening recommendation also wanted all the available information. This suggests that advice from an expert is an important part of the decision-making process and not an alternative to it.

"The study also showed that most people in the UK have a high level of trust in the NHS, which may explain why so many people are so keen to have a clear recommendation from it."

Sara Hiom, director of information at Cancer Research UK, said: "This study gives a much clearer picture about what information people want when being invited to bowel screening. This is very timely and we hope it will help the development of new information for the public.

"The study's importance goes beyond the information provided by the NHS – it will also help cancer charities like Cancer Research UK to develop the information we offer to the public about screening.

"Cancer Research UK funds research into new methods and technologies to prevent and detect bowel cancer earlier, as well as to improve the outcomes for people who are diagnosed with bowel cancer. But it's essential that this work is coupled with accessible information for the general public."

Explore further: Bowel screening reduces cancer deaths by more than 25 per cent

More information: Waller, J., et al., Communication about colorectal cancer screening in Britain: public preferences for an expert recommendation. British Journal of Cancer DOI: 10.1038/bjc.2012.512

Related Stories

Screening helps early diagnosis of bowel cancer

June 18, 2012

(Medical Xpress) -- Patients who attend bowel screening are more likely to be diagnosed with bowel cancer at an early stage - when there is a better chance of survival - than those who wait until they have symptoms of the ...

Recommended for you

Cancer's big data problem

October 20, 2016

Data is pouring into the hands of cancer researchers, thanks to improvements in imaging, models and understanding of genetics. Today the data from a single patient's tumor in a clinical trial can add up to one terabyte—the ...

Gene fusions can lead to glioblastoma in children

October 20, 2016

Every year, about 60 children and adolescents in Germany are diagnosed with glioblastoma, a very aggressive type of brain cancer, which is still mostly untreatable. Now, scientists from the Max Planck Institute for Molecular ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.